These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35192456)

  • 1. The oxygen sensor prolyl hydroxylase domain 2 regulates the in vivo suppressive capacity of regulatory T cells.
    Ajouaou Y; Azouz A; Taquin A; Denanglaire S; Hussein H; Krayem M; Andris F; Moser M; Goriely S; Leo O
    Elife; 2022 Feb; 11():. PubMed ID: 35192456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.
    Figg WD; Fiorini G; Chowdhury R; Nakashima Y; Tumber A; McDonough MA; Schofield CJ
    Proteins; 2023 Nov; 91(11):1510-1524. PubMed ID: 37449559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PHD in immunosuppression: oxygen-sensing pathways regulate immunosuppressive Tregs.
    Zou W; Shah YM
    J Clin Invest; 2019 Jul; 129(9):3524-3526. PubMed ID: 31355780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
    Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
    Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid PHD2 deficiency accelerates neointima formation via Hif-1α.
    Christoph M; Pfluecke C; Mensch M; Augstein A; Jellinghaus S; Ende G; Mierke J; Franke K; Wielockx B; Ibrahim K; Poitz DM
    Mol Immunol; 2022 Sep; 149():48-58. PubMed ID: 35724581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles and signaling pathways of prolyl-4-hydroxylase 2 in the tumor microenvironment.
    Li A; Zhang Y; Wang Z; Dong H; Fu N; Han X
    Chem Biol Interact; 2019 Apr; 303():40-49. PubMed ID: 30817904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial HIF2α suppresses retinal angiogenesis in neonatal mice by upregulating NOTCH signaling.
    Duan LJ; Jiang Y; Fong GH
    Development; 2024 Jun; 151(11):. PubMed ID: 38770916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α.
    Wang S; Awad KS; Chen LY; Siddique MAH; Ferreyra GA; Wang CL; Joseph T; Yu ZX; Takeda K; Demirkale CY; Zhao YY; Elinoff JM; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2024 Oct; 327(4):L503-L519. PubMed ID: 39159362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal mice.
    Duan LJ; Takeda K; Fong GH
    Am J Pathol; 2011 Apr; 178(4):1881-90. PubMed ID: 21435465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
    Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel prolyl hydroxylase 2 gene from mud crab Scylla paramamosain: Insights into its role in the regulation of hypoxia-inducible factor-1α.
    Jie YK; Jiang JJ; Ma HL; Cheng CH; Liu GX; Fan SG; Feng J; Guo ZX
    Comp Biochem Physiol C Toxicol Pharmacol; 2023 Jul; 269():109634. PubMed ID: 37086960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress.
    Singh RP; Franke K; Kalucka J; Mamlouk S; Muschter A; Gembarska A; Grinenko T; Willam C; Naumann R; Anastassiadis K; Stewart AF; Bornstein S; Chavakis T; Breier G; Waskow C; Wielockx B
    Blood; 2013 Jun; 121(26):5158-66. PubMed ID: 23667053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer.
    Su Y; Loos M; Giese N; Metzen E; Büchler MW; Friess H; Kornberg A; Büchler P
    Cancer; 2012 Feb; 118(4):960-72. PubMed ID: 21792862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms.
    Schultz K; Murthy V; Tatro JB; Beasley D
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L921-7. PubMed ID: 19304911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway.
    Xiang L; Wei H; Ye W; Wu S; Xie G
    Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 37975227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHD2 Constrains Antitumor CD8+ T-cell Activity.
    Bisilliat Donnet C; Acolty V; Azouz A; Taquin A; Henin C; Trusso Cafarello S; Denanglaire S; Mazzone M; Oldenhove G; Leo O; Goriely S; Moser M
    Cancer Immunol Res; 2023 Mar; 11(3):339-350. PubMed ID: 36603132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic PHD2/HIF-1α axis is involved in postexercise systemic energy homeostasis.
    Luo B; Xiang D; Wu D; Liu C; Fang Y; Chen P; Hu YP
    FASEB J; 2018 Sep; 32(9):4670-4680. PubMed ID: 29601782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ATP13A2 via PHD2-HIF1α Signaling Is Critical for Cellular Iron Homeostasis: Implications for Parkinson's Disease.
    Rajagopalan S; Rane A; Chinta SJ; Andersen JK
    J Neurosci; 2016 Jan; 36(4):1086-95. PubMed ID: 26818499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice.
    Kalucka J; Ettinger A; Franke K; Mamlouk S; Singh RP; Farhat K; Muschter A; Olbrich S; Breier G; Katschinski DM; Huttner W; Weidemann A; Wielockx B
    Mol Cell Biol; 2013 Sep; 33(17):3426-38. PubMed ID: 23798557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia.
    Su K; Li Z; Zhang L; Fang S; Mao M; Sun Z; Zhang X
    Eur J Med Chem; 2022 Aug; 238():114479. PubMed ID: 35675755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.